drugset / Trial / NCT03279744

A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion

NCT03279744 ↗

Phase 2 Completed 25 enrolled Pharma Power Biotec Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

A Prospective, Single-Arm, Open-Label, Phase II Study to Evaluate the Efficacy and Safety of Photodynamic Therapy Using Radion™-pdt in Patients with Oral Precancerous Lesion (Oral Verrucous Hyperplasia or Oral Erythroleukoplakia).

Timeline

Start
2017-09-06
Primary completion
2019-09-04
Completion
2019-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Radion™-Pdt Unknown 0.1 unknown Topical

Indications